Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14121 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Giada Bianchetti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Biophysics Section, Catholic University of the Sacred Heart, Rome, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Foundation for the Study of Diabetes, Grant for "Innovative Measurements of Diabetes Outcomes 2018", Fondazione Associazione Medici Diabetologi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Improving the composition of circulating fatty acids (FA) leads to a reduction in cardiovascular diseases (CVD) in high‐risk individuals. The membrane fluidity of red blood cells (RBC), which reflects circulating FA status, may be a valid biomarker of cardiovascular (CV) risk in type 2 diabetes (T2D).
Methods
Red blood cell membrane fluidity, quantified as general polarization (GP), was assessed in 234 subjects with T2D, 86 with prior major CVD. Based on GP distribution, a cut‐off of .445 was used to divide the study cohort into two groups: the first with higher GP, called GEL, and the second, defined as lower GP (LGP). Lipidomic analysis was performed to evaluate FA composition of RBC membranes.
Results
Although with comparable CV risk factors, the LGP group had a greater percentage of patients with major CVD than the GEL group (40% vs 24%, respectively, p < .05). Moreover, in a logistic regression analysis, a lower GP value was independently associated with the presence of macrovascular complications. Lipidomic analysis showed a clear shift of LGP membranes towards a pro‐inflammatory condition due to higher content of arachidonic acid and increased omega 6/omega 3 index.
Conclusions
Increased membrane fluidity is associated with a higher CV risk in subjects with T2D. If confirmed in prospective studies, membrane fluidity could be a new biomarker for residual CV risk assessment in T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, Biophysics Section, Catholic University of the Sacred Heart, Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Rome, Italy.
- Department of Medical and Surgical Sciences, Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- CNR ISOF, National Research Council, ISOF, Bologna, Italy.
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Giada Bianchetti, Chiara Maria Assunta Cefalo, Andrea Giaccari, Giuseppe Maulucci
Förderung
- European Foundation for the Study of Diabetes
- Grant for "Innovative Measurements of Diabetes Outcomes 2018"
- Fondazione Associazione Medici Diabetologi
- Scholarship Adolfo Arcangeli to CMAC
- Italian Ministry of Education, University and Research
- Università Cattolica del Sacro Cuore
- Italian Ministry of University and Research
Zitieren
APA
Bianchetti, G., Cefalo, C. M. A., Ferreri, C., Sansone, A., Vitale, M., Serantoni, C., Abeltino, A., Mezza, T., Ferraro, P. M., De Spirito, M., Riccardi, G., Giaccari, A., & Maulucci, G. (2024). Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14121
Vancouver
Bianchetti G, Cefalo CMA, Ferreri C, Sansone A, Vitale M, Serantoni C, et al. Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14121
BibTeX
@article{Bianchetti2024,
author = {Bianchetti, Giada and Cefalo, Chiara Maria Assunta and Ferreri, Carla and Sansone, Anna and Vitale, Marilena and Serantoni, Cassandra and Abeltino, Alessio and Mezza, Teresa and Ferraro, Pietro Manuel and De Spirito, Marco and Riccardi, Gabriele and Giaccari, Andrea and Maulucci, Giuseppe},
title = {Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14121}
}
EUVIMED